Product Information
TOPIRAMATE 50 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0345 per EA under NDC 69097012312. Its NADAC has been published 596 times since Jan 28, 2015.
Strength
50 mg/1
Manufacturer
Cipla USA Inc.NDC
69097012312
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA076343On Market Since
6/12/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 50 MG TABLET has been published 596 times since Jan 28, 2015, and over the history we have for it it has declined 55.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0345 per EA |
|---|---|
| All-time high | $0.0767 (Feb 11, 2015) |
| All-time low | $0.0319 (Nov 20, 2024) |
| 52-week high | $0.0394 |
| 52-week low | $0.0345 |
| Median price | $0.0488 |
| Average price | $0.0481 |
| Largest weekly change | +31.7% (Aug 21, 2024) |
| Weeks tracked | 596 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 50 MG TABLET, manufactured by Cipla USA Inc., is $0.0345 per EA (NDC 69097012312), effective Jun 24, 2026.
How has the price of TOPIRAMATE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 50 MG TABLET has declined 55.0%. It has been tracked across 596 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 50 MG TABLET?
Since Jan 28, 2015, the NADAC for TOPIRAMATE 50 MG TABLET has ranged from a low of $0.0319 (Nov 20, 2024) to a high of $0.0767 (Feb 11, 2015), with a median of $0.0488 per EA.
Are there cheaper alternatives to TOPIRAMATE 50 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TOPIRAMATE 50 MG TABLET, but none are currently priced below it.
Who manufactures TOPIRAMATE 50 MG TABLET?
TOPIRAMATE 50 MG TABLET (NDC 69097012312) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification